STEPHANIE PURVIS: Open Payments
NPI 1942754858 · PENNINGTON GAP, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 27 payments from 14 companies in 2025. Trend: 2023 $37 · 2024 $0 · 2025 $570
Food & beverage: $570
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $89 |
| Novo Nordisk Inc | 4 | $87 |
| Astellas Pharma US Inc | 3 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $63 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Dexcom, Inc. | 1 | $37 |
| ABBVIE INC. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| INOGEN, INC. | 1 | $24 |
| Abbott Laboratories | 1 | $22 |
Products named: Veozah, CAPLYTA, AIRSUPRA, ELIQUIS, Auvelity, Dexcom G6 Transmitter, Kerendia, FARXIGA.
Industry payments across VA — which companies pay providers there.
